Offstream
news

The U.S. Food and Drug Administration says that it has granted priority review for the vaccine developed by Pfizer and BioNTech. A decision on whether to fully approve the vaccine will likely be made within two months.
2021-07-16

The government signs a deal with Pfizer and BioNTech to buy an additional 12.2 million doses of the tozinameran vaccine.
2021-01-11

Singapore officially begins its vaccination campaign against COVID-19, with healthcare workers being among the first to receive the Pfizer-BioNTech vaccine tozinameran.
2020-12-30

Spain receives its first shipment of the Pfizer-BioNTech vaccine tozinameran in Guadalajara, a day before the country begins its vaccination programme.
2020-12-26

Serbia officially begins its vaccination programme against COVID-19, with Prime Minister Ana Brnabić becoming the first person to receive the Pfizer-BioNTech vaccine.
2020-12-24

Mexico begins vaccinations with the Pfizer-BioNTech vaccine. An intensive care unit nurse in Mexico City becomes the first person in the country to receive the vaccine.
2020-12-24

Qatar begins administering the Pfizer-BioNTech vaccine tozinameran to its citizens at designated health centers in the country. Those aged over 70, adults with chronic health conditions and healthcare personnel are to be prioritised for the vaccine.
2020-12-23

The European Medicines Agency conditionally approves the vaccine made by Pfizer and BioNTech for use in European Union countries.
2020-12-21

Pfizer and BioNTech announce that they have started shipping their vaccine from a Michigan facility to all 50 states.
2020-12-13

The United Kingdom's National Health Service begins a mass vaccination campaign against COVID-19 using the BNT162b2 vaccine developed by BioNTech and Pfizer. Seniors over the age of 80 and certain healthcare workers will be among the first to receive the vaccine.
2020-12-8